Status:
COMPLETED
The Clinical Practice of Palliative Sedation
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
European Union
European Association for Palliative Care (EAPC)
Conditions:
Palliative Sedation
Eligibility:
All Genders
18+ years
Brief Summary
Palliative Sedation (PS) is defined as the intentional lowering of consciousness of a patient in the last phase of life, to relieve patients suffering from refractory symptoms. For those symptoms all ...
Eligibility Criteria
Inclusion
- Phase 1: Participants are eligible for participation in this study when they meet all the following criteria:
- Adults;
- with advanced cancer;
- and a limited life expectancy (1- 2 months);
- according the health care team, intractable distress caused by one or more refractory symptoms can be expected or is present during the hospitalization.
- Participants can enter Phase 2 of this study when fulfilling the following preconditions:
- inclusion criteria for phase 1 are met and informed consent is given by the participant;
- participant is suffering from intractable distress caused by one or more refractory symptoms according the health care team and/or participant and relatives;
- sedative medication is started with the aim to relieve burden of otherwise intractable suffering (palliative sedation)
- Exclusion Criteria:
- a potential participant is unable to give informed consent;
- a potential participant is unable to speak and read in the native language of the participating country.
Exclusion
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04719702
Start Date
April 20 2021
End Date
July 31 2023
Last Update
July 3 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholieke Universiteit Leuven
Leuven, Belgium
2
Universitätsklinikum Bonn
Bonn, Germany, 53127
3
La Maddalena Spa
Palermo, Italy, 90146
4
Rijnstate Ziekenhuis
Arnhem, Netherlands, 6815 AD